Elderly woman to take on Monsanto in next trial over cancer claims
By Carey Gillam View original US Right To Know article
By Carey Gillam View original US Right To Know article
By Sara Randazzo View original Wall Street Journal Article
Trammell PC has received numerous inquiries this summer about the status of the Johnson & Johnson talcum powder litigation. We represent thousands of clients with claims against Johnson & Johnson for failure to disclose the risks of using talcum powder, and continue to hear from people who have been diagnosed with gynecological cancers or mesothelioma …
What’s Happening With The Johnson & Johnson Talcum Powder Litigation? Read More »
At Trammell PC, we are involved in litigating an array of mass torts—lawsuits that bring together many people who were injured by the same drug or device. Like many other facets of American life, processes related to mass torts have seen some changes since the rise of the novel coronavirus and the COVID-19 pandemic. Some …
Drug and Device Cases Are Going Strong Despite the Coronavirus Read More »
By Lynne Higby View original Medtruth article
At Trammell PC, we represent people who were injured by hernia mesh implants. These cases go back a very long time—but they may soon come to an end. Despite the delays created by the novel coronavirus, the federal multidistrict litigation is slated to start “bellwether” trials on September 29. The consolidated action in Rhode Island …
Bard Hernia Mesh Settlement Potentially on the Horizon Read More »
By Maria Dinezo View original Courthouse News Service article
By Jeff Feeley et al. View original Bloomberg article
By Patricia Cohen View original New York Times article
At Trammell PC, we represent people who have been injured by medications, devices, and products that were supposed to help them. By their nature, these are almost always mass torts that bring together thousands of individuals who were affected in the same way by the drug, device, or product. In this blog post, we’d like …
Mass Tort Litigation: What is it and an Update on the Essure Litigation Read More »